Historical record - last NADAC effective date: 4/17/2024
Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2412 per EA under NDC 68462056690. Its NADAC has been published 222 times since Feb 19, 2020.
FDA first approved this application on Jul 5, 2017.
The High Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5; 20 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462056690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207807FDA Approved
7/5/2017
On Market Since
7/5/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 222 times since Feb 19, 2020, and over the history we have for it it has declined 62.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2412 per EA |
|---|---|
| All-time high | $0.7086 (Apr 15, 2020) |
| All-time low | $0.2412 (Apr 17, 2024) |
| Median price | $0.4106 |
| Average price | $0.4299 |
| Largest weekly change | +64.3% (Jul 21, 2021) |
| Weeks tracked | 222 |
| Tracking since | Feb 19, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-44.5%
5Y
-47.6%
All
-62.0%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2412 per EA (NDC 68462056690), effective May 15, 2024.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 62.0%. It has been tracked across 222 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Feb 19, 2020, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2412 (Apr 17, 2024) to a high of $0.7086 (Apr 15, 2020), with a median of $0.4106 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 5-20 MG, is $0.2257 per EA — about 6% below AMLODIPINE-OLMESARTAN 5-20 MG.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 68462056690) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.